| Primary |
| Coronary Arterial Stent Insertion |
37.2% |
| Stent Placement |
14.0% |
| Coronary Artery Disease |
11.6% |
| Antiplatelet Therapy |
9.3% |
| Dermatitis Allergic |
4.7% |
| Postoperative Care |
4.7% |
| Angiogram |
2.3% |
| Catheterisation Cardiac |
2.3% |
| Cerebrovascular Accident Prophylaxis |
2.3% |
| Cerebrovascular Disorder |
2.3% |
| Coronary Stent Insertion |
2.3% |
| Coronary Stent Placement |
2.3% |
| Drug-eluting Coronary Stent Placement |
2.3% |
| Surgery |
2.3% |
|
| Rash |
14.8% |
| Angina Unstable |
7.4% |
| Haemorrhage |
7.4% |
| Thrombosis In Device |
7.4% |
| Treatment Failure |
7.4% |
| Cerebral Haemorrhage |
3.7% |
| Chromaturia |
3.7% |
| Dizziness |
3.7% |
| Drug Ineffective |
3.7% |
| Fall |
3.7% |
| Gastric Haemorrhage |
3.7% |
| Gastrointestinal Haemorrhage |
3.7% |
| Haemoglobin Decreased |
3.7% |
| Haemorrhage Intracranial |
3.7% |
| Haemorrhagic Stroke |
3.7% |
| Hypertension |
3.7% |
| Pain |
3.7% |
| Platelet Count Decreased |
3.7% |
| Road Traffic Accident |
3.7% |
| Thrombotic Thrombocytopenic Purpura |
3.7% |
|
| Secondary |
| Product Used For Unknown Indication |
16.6% |
| Acute Coronary Syndrome |
14.3% |
| Percutaneous Coronary Intervention |
9.2% |
| Acute Myocardial Infarction |
7.8% |
| Drug Use For Unknown Indication |
6.5% |
| Antiplatelet Therapy |
6.0% |
| Coronary Artery Disease |
5.1% |
| Myocardial Infarction |
4.6% |
| Dyslipidaemia |
3.7% |
| Ill-defined Disorder |
3.7% |
| Hypertension |
3.2% |
| Platelet Count Increased |
2.8% |
| Prevention |
2.8% |
| Stent Placement |
2.8% |
| Myocardial Ischaemia |
2.3% |
| Back Pain |
1.8% |
| Coagulopathy |
1.8% |
| Thrombosis Prophylaxis |
1.8% |
| Vitamin Supplementation |
1.8% |
| Cardiovascular Event Prophylaxis |
1.4% |
|
| Thrombocytopenia |
11.4% |
| Haemorrhage Intracranial |
9.1% |
| Coronary Angioplasty |
6.8% |
| Retroperitoneal Haematoma |
6.8% |
| Cardiogenic Shock |
4.5% |
| Coma Scale Abnormal |
4.5% |
| Coronary Artery Thrombosis |
4.5% |
| Cytolytic Hepatitis |
4.5% |
| Duodenal Ulcer Haemorrhage |
4.5% |
| Epistaxis |
4.5% |
| Haematocrit Decreased |
4.5% |
| Melaena |
4.5% |
| Pneumonia |
4.5% |
| Puncture Site Haemorrhage |
4.5% |
| Rhabdomyolysis |
4.5% |
| Subarachnoid Haemorrhage |
4.5% |
| Systemic Inflammatory Response Syndrome |
4.5% |
| Adverse Drug Reaction |
2.3% |
| Agitation |
2.3% |
| Altered State Of Consciousness |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.7% |
| Myocardial Infarction |
8.7% |
| Drug Use For Unknown Indication |
8.1% |
| Acute Myocardial Infarction |
7.4% |
| Hypertension |
6.1% |
| Percutaneous Coronary Intervention |
5.7% |
| Premedication |
5.2% |
| Anticoagulant Therapy |
3.7% |
| Hypersensitivity |
3.5% |
| Antiplatelet Therapy |
3.1% |
| Prophylaxis |
3.1% |
| Acute Coronary Syndrome |
2.8% |
| Cardiac Failure |
2.6% |
| Myocardial Ischaemia |
2.6% |
| Pain |
2.4% |
| Stent Placement |
2.4% |
| Antibiotic Prophylaxis |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Depression |
2.0% |
| Angina Pectoris |
1.5% |
|
| Myocardial Infarction |
11.9% |
| Rhabdomyolysis |
10.4% |
| Tachycardia |
10.4% |
| Thrombosis In Device |
9.0% |
| Incorrect Route Of Drug Administration |
7.5% |
| Hypotension |
4.5% |
| Impaired Driving Ability |
4.5% |
| Off Label Use |
4.5% |
| Vascular Operation |
4.5% |
| Acute Coronary Syndrome |
3.0% |
| Acute Myocardial Infarction |
3.0% |
| Bradycardia |
3.0% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Coronary Artery Restenosis |
3.0% |
| Flushing |
3.0% |
| Hyperbilirubinaemia |
3.0% |
| Malaise |
3.0% |
| Normochromic Normocytic Anaemia |
3.0% |
| Pain In Extremity |
3.0% |
| Peripheral Arterial Occlusive Disease |
3.0% |
|
| Interacting |
| Antiplatelet Therapy |
38.0% |
| Product Used For Unknown Indication |
13.0% |
| Acute Myocardial Infarction |
8.7% |
| Coronary Artery Disease |
6.5% |
| Atrial Fibrillation |
4.3% |
| Carotid Artery Aneurysm |
4.3% |
| Catheterisation Cardiac |
3.3% |
| Cerebrovascular Accident Prophylaxis |
3.3% |
| Ischaemic Heart Disease Prophylaxis |
3.3% |
| Blood Pressure Abnormal |
2.2% |
| Intracranial Aneurysm |
2.2% |
| Stent Placement |
2.2% |
| Agitation |
1.1% |
| Arrhythmia |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Coronary Angioplasty |
1.1% |
| Diabetes Mellitus |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Hypotension |
1.1% |
| Hypothyroidism |
1.1% |
|
| Vessel Perforation |
22.2% |
| Upper Gastrointestinal Haemorrhage |
16.7% |
| Labelled Drug-drug Interaction Medication Error |
11.1% |
| Anaemia |
5.6% |
| Epistaxis |
5.6% |
| Gastrointestinal Haemorrhage |
5.6% |
| Haematochezia |
5.6% |
| Haemoglobin Decreased |
5.6% |
| Haemorrhage |
5.6% |
| Incision Site Haemorrhage |
5.6% |
| Myocardial Infarction |
5.6% |
| Myocardial Ischaemia |
5.6% |
|
